中东和非洲慢病毒载体市场报告– 行业趋势和2028年预测

>中东和非洲慢病毒载体市场，按组件（慢病毒启动子、慢病毒融合标签、慢病毒包装系统、其他）、类型（产品、服务）、代数（第 4 代、第 3 代、第 2 代、第 1 代）、工作流程（上游处理、下游处理）、递送方法（体内、体外）、疾病指征（癌症、遗传性疾病、传染病、兽医疾病、其他）、应用（基因治疗、疫苗学）、最终用户（生物技术公司、制药公司、合同研究组织、合同开发和制造组织 (CDMO)、学术/研究机构）、国家（南非、沙特阿拉伯、阿联酋、埃及、以色列和中东及非洲其他地区）行业趋势和预测 2028

市场分析和见解：中东和非洲慢病毒载体市场

慢病毒载体市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场以 16.1% 的复合年增长率增长，预计到 2028 年将达到 2.0737 亿美元。慢病毒载体的需求不断增长和传染病的增加是预测期内推动市场需求的主要驱动力。

慢病毒载体 (LV) 是哺乳动物细胞中基因转移的有效载体，因为它们能够在非分裂细胞和分裂细胞中稳定表达目标基因。慢病毒是人类和动物病原体，已知其潜伏期长且感染持续。从初次感染到出现首批症状之间的时间可能长达数月或数年。

分子生物学家经常使用病毒载体将遗传物质运送到细胞中。这个过程可以在体内（活体生物体内）或细胞培养（体外）中进行。病毒已经发展出专门的分子机制，可以有效地将其基因组运送到它们感染的细胞内。

在此次 Covid-19 爆发期间，老年人口的增长和对疫苗开发的需求有效地促进了慢病毒载体市场的增长。然而，慢病毒载体缺乏可扩展性和下游纯化的局限性可能会阻碍慢病毒载体市场的未来增长。主要市场参与者的战略举措和基因组学资金的增加为亚太地区慢病毒载体市场的增长提供了机遇。与慢病毒载体产品相关的严格监管政策和副作用对未来的市场增长构成了挑战。

慢病毒载体市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。

中东和非洲慢病毒载体市场范围和市场规模

慢病毒载体市场根据成分、类型、生成、工作流程、交付方法、疾病指征、应用和最终用户分为八个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

根据成分，慢病毒载体市场细分为慢病毒启动子、慢病毒融合标签、慢病毒包装系统和其他。由于医疗保健支出不断增加，预计 2021 年慢病毒包装系统部分将主导慢病毒载体市场。
根据类型，慢病毒载体市场分为产品和服务。由于遗传病发病率高，预计 2021 年产品部分将主导慢病毒载体市场。
根据代数，慢病毒载体市场分为第四代、第三代、第二代和第一代。由于积极的研发活动，预计到 2021 年，第四代将主导慢病毒载体市场。
根据工作流程，慢病毒载体市场分为上游加工和下游加工。由于技术的进步，预计到 2021 年，上游加工部分将主导慢病毒载体市场。
根据递送方式，慢病毒载体市场分为体内和体外。2021 年，由于效率更高，体内载体市场预计将在慢病毒载体市场中占据主导地位。
根据疾病适应症，慢病毒载体市场细分为癌症、遗传性疾病、传染病、兽医疾病和其他疾病。由于中东和非洲地区老年人和癌症病例的增加，预计 2021 年癌症领域将主导慢病毒载体市场。
根据应用，慢病毒载体市场细分为基因治疗和疫苗学。由于人们对基因治疗的认识不断提高以及临床试验批准的不断增加，预计 2021 年基因治疗领域将主导慢病毒载体市场。
根据最终用户，慢病毒载体市场分为生物技术公司、制药公司、合同研究组织、合同开发和制造组织 (CDMO) 和学术/研究机构。由于政府对基因治疗研发部门的资金增加，预计 2021 年学术/研究机构将主导慢病毒载体市场。

慢病毒载体市场国家级分析

对慢病毒载体市场进行了分析，并按上述国家、组成部分、类型、代数、工作流程、递送方式、疾病指征、应用和最终用户提供了市场规模信息。

慢病毒载体市场报告涵盖的国家包括沙特阿拉伯、南非、阿联酋、以色列、埃及、中东和非洲其他地区。

由于对研究活动的投资不断增加，预计中东和非洲地区的上游加工部门将在 2021 年至 2028 年的预测期内以最高增长率增长。南非引领中东和非洲市场的增长，由于政府对研发活动技术改进的资金不断增加，上游加工部门在该地区占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。

制造商的战略举措为慢病毒载体市场参与者创造新机遇

慢病毒载体市场还为您提供每个国家增长的详细市场分析。此外，它还提供有关亚太地区市场参与者之间的慢病毒载体销售、合作伙伴关系、收购、分销协议增长的详细数据。数据适用于 2010 年至 2019 年的历史时期。

竞争格局和慢病毒载体市场份额分析

慢病毒载体市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对慢病毒载体市场的关注有关。

从事慢病毒载体市场报告的主要公司包括 Merck KGaA、Sirion-Biotech GmbH、Thermo Fisher Scientific Inc.、Applied Biological Materials Inc.、Creative Biolabs、System Biosciences, LLC、Takara Bio Inc.、OriGene Technologies, Inc.、Sino Biological, Inc.、Lonza 以及其他国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。

全球各地的公司也签订了许多合同和协议，这也加速了慢病毒载体市场的发展。

例如，

2021 年 2 月，赛默飞世尔科技公司宣布在年度 CMO 领导力奖中获得六个奖项。生命科学领袖和外包制药公司颁发的奖项旨在表彰生物制药和生物技术公司评选出的顶级合同制造合作伙伴。据估计，这一认可有望加强其全球影响力，并在未来几年推动其增长。

市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业等策略正在增强公司在慢病毒载体市场的影响力，这也为组织的利润增长带来了好处。

SKU-63336

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 THERMO FISHER SCIENTIFIC

TABLE 2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN

TABLE 3 KERAFAST

TABLE 4 APPLIED BIOLOGICAL MATERIALS INC.

TABLE 5 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA LENTIVIRUS PACKAGING SYSTEMS IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA LENTIVIRAL PROMOTER IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA LENTIVIRAL PROMOTER IN LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA LENTIVIRAL FUSION TAGS IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA PRODUCT IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA PRODUCT IN LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA SERVICES IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY GENERATION, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA 4TH-GENERATION IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA 3RD-GENERATION IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA 2ND-GENERATION IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA 1ST-GENERATION IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY WORK FLOW, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA IN-VIVO IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA EX-VIVO IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA CANCER IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA VETERINARY DISEASES IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA OTHERS IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA GENE THERAPY IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA GENE THERAPY IN LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA VACCINOLOGY IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA ACADEMIC/ RESEARCH INSTITUTES IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA PHARMACEUTICAL COMPANIES IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA LENTIVIRAL PROMOTER IN LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA PRODUCT IN LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY GENERATION, 2019-2028 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 58 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 59 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA GENE THERAPY IN LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 62 SOUTH AFRICA LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 63 SOUTH AFRICA LENTIVIRAL PROMOTER IN LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 64 SOUTH AFRICA LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 SOUTH AFRICA PRODUCT IN LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 SOUTH AFRICA LENTIVIRAL VECTOR MARKET, BY GENERATION, 2019-2028 (USD MILLION)

TABLE 67 SOUTH AFRICA LENTIVIRAL VECTOR MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 68 SOUTH AFRICA UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 69 SOUTH AFRICA DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 70 SOUTH AFRICA LENTIVIRAL VECTOR MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 71 SOUTH AFRICA LENTIVIRAL VECTOR MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 72 SOUTH AFRICA GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 73 SOUTH AFRICA INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 74 SOUTH AFRICA LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 SOUTH AFRICA GENE THERAPY IN LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 76 SOUTH AFRICA LENTIVIRAL VECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 77 SAUDI ARABIA LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 78 SAUDI ARABIA LENTIVIRAL PROMOTER IN LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 79 SAUDI ARABIA LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 80 SAUDI ARABIA PRODUCT IN LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 SAUDI ARABIA LENTIVIRAL VECTOR MARKET, BY GENERATION, 2019-2028 (USD MILLION)

TABLE 82 SAUDI ARABIA LENTIVIRAL VECTOR MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 83 SAUDI ARABIA UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 84 SAUDI ARABIA DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 85 SAUDI ARABIA LENTIVIRAL VECTOR MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 86 SAUDI ARABIA LENTIVIRAL VECTOR MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 87 SAUDI ARABIA GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 88 SAUDI ARABIA INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 89 SAUDI ARABIA LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 90 SAUDI ARABIA GENE THERAPY IN LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 91 SAUDI ARABIA LENTIVIRAL VECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 92 U.A.E. LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 93 U.A.E. LENTIVIRAL PROMOTER IN LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 94 U.A.E. LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 95 U.A.E. PRODUCT IN LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 U.A.E. LENTIVIRAL VECTOR MARKET, BY GENERATION, 2019-2028 (USD MILLION)

TABLE 97 U.A.E. LENTIVIRAL VECTOR MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 98 U.A.E. UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 99 U.A.E. DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 100 U.A.E. LENTIVIRAL VECTOR MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 101 U.A.E. LENTIVIRAL VECTOR MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 102 U.A.E. GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 103 U.A.E. INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 104 U.A.E. LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 105 U.A.E. GENE THERAPY IN LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 106 U.A.E. LENTIVIRAL VECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 107 EGYPT LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 108 EGYPT LENTIVIRAL PROMOTER IN LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 109 EGYPT LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 110 EGYPT PRODUCT IN LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 111 EGYPT LENTIVIRAL VECTOR MARKET, BY GENERATION, 2019-2028 (USD MILLION)

TABLE 112 EGYPT LENTIVIRAL VECTOR MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 113 EGYPT UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 114 EGYPT DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 115 EGYPT LENTIVIRAL VECTOR MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 116 EGYPT LENTIVIRAL VECTOR MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 117 EGYPT GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 118 EGYPT INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 119 EGYPT LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 120 EGYPT GENE THERAPY IN LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 121 EGYPT LENTIVIRAL VECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 122 ISRAEL LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 123 ISRAEL LENTIVIRAL PROMOTER IN LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

TABLE 124 ISRAEL LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 125 ISRAEL PRODUCT IN LENTIVIRAL VECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 126 ISRAEL LENTIVIRAL VECTOR MARKET, BY GENERATION, 2019-2028 (USD MILLION)

TABLE 127 ISRAEL LENTIVIRAL VECTOR MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)

TABLE 128 ISRAEL UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 129 ISRAEL DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 130 ISRAEL LENTIVIRAL VECTOR MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)

TABLE 131 ISRAEL LENTIVIRAL VECTOR MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 132 ISRAEL GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 133 ISRAEL INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 134 ISRAEL LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 135 ISRAEL GENE THERAPY IN LENTIVIRAL VECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 136 ISRAEL LENTIVIRAL VECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 137 REST OF MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET, BY COMPONENT, 2019-2028 (USD MILLION)

图片列表

FIGURE 1 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: SEGMENTATION

FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 LENTIVIRUS PACKAGING SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET

FIGURE 15 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY COMPONENT, 2020

FIGURE 16 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY COMPONENT, 2019-2028 (USD MILLION)

FIGURE 17 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY COMPONENT, CAGR (2021-2028)

FIGURE 18 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY COMPONENT, LIFELINE CURVE

FIGURE 19 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY TYPE, 2020

FIGURE 20 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 21 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 22 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY GENERATION, 2020

FIGURE 24 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY GENERATION, 2019-2028 (USD MILLION)

FIGURE 25 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY GENERATION, CAGR (2021-2028)

FIGURE 26 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY GENERATION, LIFELINE CURVE

FIGURE 27 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY WORK FLOW, 2020

FIGURE 28 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY WORK FLOW, 2019-2028 (USD MILLION)

FIGURE 29 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY WORK FLOW, CAGR (2021-2028)

FIGURE 30 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY WORK FLOW, LIFELINE CURVE

FIGURE 31 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY DELIVERY METHOD, 2020

FIGURE 32 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY DELIVERY METHOD, 2019-2028 (USD MILLION)

FIGURE 33 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY DELIVERY METHOD, CAGR (2021-2028)

FIGURE 34 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY DELIVERY METHOD, LIFELINE CURVE

FIGURE 35 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY DISEASE INDICATION, 2020

FIGURE 36 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)

FIGURE 37 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY DISEASE INDICATION, CAGR (2021-2028)

FIGURE 38 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY DISEASE INDICATION, LIFELINE CURVE

FIGURE 39 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY APPLICATION, 2020

FIGURE 40 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY APPLICATION, 2019-2028 (USD MILLION)

FIGURE 41 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 42 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 43 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY END USER, 2020

FIGURE 44 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 45 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY END USER, CAGR (2021-2028)

FIGURE 46 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY END USER, LIFELINE CURVE

FIGURE 47 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: SNAPSHOT (2020)

FIGURE 48 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY COUNTRY (2020)

FIGURE 49 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY COUNTRY (2021 & 2028)

FIGURE 50 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY COUNTRY (2020 & 2028)

FIGURE 51 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: BY COMPONENT (2021-2028)

FIGURE 52 MIDDLE EAST AND AFRICA LENTIVIRAL VECTOR MARKET: COMPANY SHARE 2020 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

中东和非洲慢病毒载体市场 – 行业趋势和 2028 年预测

中东和非洲慢病毒载体市场 – 行业趋势和 2028 年预测

市场分析和见解：中东和非洲慢病毒载体市场

中东和非洲慢病毒载体市场范围和市场规模

慢病毒载体市场国家级分析

竞争格局和慢病毒载体市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

报告

市场洞察

支持

解决方案

中东和非洲慢病毒载体市场 – 行业趋势和 2028 年预测

中东和非洲慢病毒载体市场 – 行业趋势和 2028 年预测

市场分析和见解：中东和非洲慢病毒载体市场

中东和非洲慢病毒载体市场范围和市场规模

慢病毒载体市场国家级分析

竞争格局和慢病毒载体市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

浏览相关页面